[June 27, 2019 Dear Shareholders, We had a solid start to 2019, and I am pleased with our first quarter results. We continued to execute on our strategy and reported strong top-line performance. Revenue grew 134% sequentially to $13.1 million, which was above the high end of our guidance range. The s]
[June 27, 2019 Dear Shareholders, We had a solid start to 2019, and I am pleased with our first quarter results. We continued to execute on our strategy and reported strong top-line performance. Revenue grew 134% sequentially to $13.1 million, which was above the high end of our guidance range. The s]
[Jun Zhu 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) (b) ¨ 3 SEC USE ONLY 4 SOURCE OF FUNDS (See Instructions) PF, OO 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of Singapore]
[TABLE OF CONTENTS TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED MARCH 31, 2019 Page PART I. Item 1. Business. 1 Item 1A. Risk Factors. 16 Item 1B. Unresolved Staff Comments. 33 Item 2. Properties. 34 Item 3. Legal Proceedings. 34 Item 4. Mine Safety Disclosures. 34 PART II. Item 5. 35 Item 6. Selecte]
[TABLE OF CONTENTS TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED MARCH 31, 2019 Page PART I. Item 1. Business. 1 Item 1A. Risk Factors. 16 Item 1B. Unresolved Staff Comments. 33 Item 2. Properties. 34 Item 3. Legal Proceedings. 34 Item 4. Mine Safety Disclosures. 34 PART II. Item 5. 35 Item 6. Selecte]
[China Jo-Jo Drugstores Reports Fiscal Year 2019 Financial Results HANGZHOU, China, July 1, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare pr]
[China Jo-Jo Drugstores Reports Fiscal Year 2019 Financial Results HANGZHOU, China, July 1, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare pr]
[June 27, 2019 Dear Shareholders, We had a solid start to 2019, and I am pleased with our first quarter results. We continued to execute on our strategy and reported strong top-line performance. Revenue grew 134% sequentially to $13.1 million, which was above the high end of our guidance range. The s]
